enVVeno Medical Corp (NVNO)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $4.29M
Last updated: Nov 17, 2026 at 11:01 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 25.7% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 30.4, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about NVNO
News
NVNO Valuation
- P/B
- 0.2x
NVNO Profitability: Margins, ROIC and FCF
enVVeno Medical (NVNO) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -67.1%
enVVeno Medical Competitors
The companies most similar to enVVeno Medical (NVNO) include Vivos Therapeutics, Nuwellis and Beyond Air.
Sector: Healthcare
Companies most similar to enVVeno MedicalNVNO Earnings: Beat Rate and Next Report
enVVeno Medical (NVNO) beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate (50.0%). Its next report is expected on Mar 24, 2027.
- Beat rate
- 4 of 8 quarters (50.0%)
- Average surprise
- -3.5%
- EPS estimate (fiscal period ending Mar 31, 2027)
- -$1.86
- Estimate revisions (30 days, fiscal period ending Mar 31, 2027)
- 0 up, 1 down
NVNO Earnings Date
NVNO reports Mar 24, 2027. The date is estimated.
Updated Oct 29, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About NVNO
When does NVNO report earnings?
enVVeno Medical Corp (NVNO) is expected to report earnings on Mar 24, 2027.
Does NVNO pay dividends?
enVVeno Medical Corp (NVNO) does not currently pay a regular dividend.
What is NVNO's market cap?
enVVeno Medical Corp (NVNO) has a market capitalization of $4.29M with a current stock price of $5.95.
NVNO pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.